SGLT2i in Kidney Stones
NCT07055282
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Kidney Stones
Interventions
DRUG:
Empagliflozin (Jardiance®)
Sponsor
University of Chicago
Collaborators
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)